Entering text into the input field will update the search result below

Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43M

May 04, 2023 5:31 PM ETCrinetics Pharmaceuticals, Inc. (CRNX)By: Gaurav Batavia, SA News Editor
  • Crinetics Pharmaceuticals press release (NASDAQ:CRNX): Q1 GAAP EPS of -$0.85 misses by $0.01.
  • Revenue of $2.67M (-14.7% Y/Y) beats by $2.43M.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About CRNX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Crinetics Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc.
IDEAYA Biosciences, Inc.
Xenon Pharmaceuticals Inc.
Rhythm Pharmaceuticals, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.